Meridian Bioscience: Q3 Earnings Insights

Meridian Bioscience VIVO reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Meridian Bioscience reported in-line EPS of $0.16 versus an estimate of $0.16.

Revenue was up $4.26 million from the same period last year.

Last quarter the company beat on EPS by $0.19 which was followed by a 1.5% drop in the share price the next day.

Here's a look at Meridian Bioscience's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	0.47	0.25	0.20	0.31
EPS Actual	0.66	0.35	0.23	0.22
Revenue Estimate	99.54M	70.29M	68.40M	77.22M
Revenue Actual	111.23M	88.34M	76.20M	63.51M

To track all earnings releases for Meridian Bioscience visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.